This essay examines neuroanatomical features that predict electroconvulsive therapy (ECT) response in treatment-resistant schizophrenia patients using MRI radiomics strategy. The study analyzed 57 patients, achieving 90.91% accuracy in predicting treatment response by extracting features from key brain regions including the inferior frontal gyrus, hippocampus, and cingulate cortex. This research demonstrates the potential for neuroimaging-based treatment selection to optimize ECT use and reduce unnecessary interventions in non-responsive patients.
Neuroanatomical Features That Predict Response to Electroconvulsive Therapy Combined with Antipsychotics in Schizophrenia: A Magnetic Resonance Imaging Study Using Radiomics Strategy
Many patients who have schizophrenia do not receive adequate treatment due to their failure to respond to antipsychotics. With over 30% of patients with schizophrenia demonstrating poor response to antipsychotics, there was a need to determine early if a patient would be responsive or not (Xi et al., 2020). Electroconvulsive therapy (ECT) is an effective alternative for treating chronic patients with refractory symptoms. ECT is only used for patients who have demonstrated unsuccessful treatment using antipsychotic medication. ECT can provoke cognitive impairment, and it is invasive compared to pharmacotherapy and costly. Therefore, before it is used for treating the patient, health care professionals should determine if the patient will be responsive to the treatment. The use of neuroimaging tools offers vital insights for assessing the likelihood of a patient responding positively to treatment. The study investigates if brain structure-based signature can be used to predict ECT response in patients with schizophrenia. There was a total of 57 patients used as the sample for the study at baseline. After treatment using ECT and antipsychotics, 28 patients were classified as responders and 29 non-responders (Xi et al., 2020). The authors found that they could accurately determine the responders with an accuracy of 90.91%. Therefore, with the possibility of determining patients who would respond positively to ECT, we can avoid implementing the treatment in patients who would be non-responders saving treatment costs and time. To predict responders and non-responders, the authors extracted features from the inferior frontal gyrus, insula, cingulate cortex, thalamus, temporal and parietal lobes, and hippocampus (Xi et al., 2020).
The study implies that we can avoid unnecessary treatment of a patient who would not be responsive to ECT treatment. Considering the invasiveness of the treatment and cost implication, it would not be fair to allow a patient to undergo treatment only for them not to receive any tangible results. As health care professionals, we have a duty to ensure that the treatment offered will be beneficial to the patient and they can recover if the treatment is administered. Therefore, when it comes to ECT use, we should only use it for patients who are responsive to the treatment (Xi et al., 2020). Having determined the accuracy of the prediction, all ECT health care professionals should only administer the treatment to patients they have analyzed and determined will positively respond to treatment.
You’re 62% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.